{{Rsnum
|rsid=1016988
|Gene=C5orf56
|Chromosome=5
|position=132408882
|Orientation=plus
|GMAF=0.2029
|Gene_s=C5orf56
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 4.4 | 28.3 | 67.3
| HCB | 8.0 | 50.4 | 41.6
| JPT | 8.0 | 53.1 | 38.9
| YRI | 0.7 | 24.5 | 74.8
| ASW | 1.8 | 19.3 | 78.9
| CHB | 8.0 | 50.4 | 41.6
| CHD | 8.3 | 36.7 | 55.0
| GIH | 15.8 | 48.5 | 35.6
| LWK | 0.0 | 16.4 | 83.6
| MEX | 3.4 | 29.3 | 67.2
| MKK | 3.2 | 21.8 | 75.0
| TSI | 6.9 | 38.6 | 54.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20031577
|Trait=Fibrinogen
|Title=Novel Loci, Including Those Related to Crohn Disease, Psoriasis, and Inflammation Identified in a Genome-Wide Association Study of Fibrinogen in 17,686 Women: The Women's Genome Health Study
|RiskAllele=G
|Pval=1E-12
|OR=6.84
|ORtxt=[NR] mg/dl decrease
|OA=1
}}

{{PMID Auto
|PMID=20031576
|Title=Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1016988
|overall_frequency_n=27
|overall_frequency_d=128
|overall_frequency=0.210938
|n_genomes=18
|n_genomes_annotated=0
|n_haplomes=19
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}